Montu and SOMAÍ make key appointments by Martin Lane November 27, 2024April 11, 2025 Montu has appointed Jodie Thomas to lead the firm’s corporate strategy, external engagement, and patient advocacy […]
Montu cites ‘confused’ TGA guidelines and argues alleged breaches were ‘divorced from their context’ by Steve Jones October 30, 2024October 30, 2024
Montu’s approach to share buy-back offer ruled ‘unacceptable’ by watchdog by Steve Jones October 25, 2024October 26, 2024
Montu advertising fight with TGA adjourned until next May by Steve Jones October 22, 2024October 24, 2024
Dolphins end Alternaleaf sponsorship over ‘challenges with regulators’ by Steve Jones October 21, 2024February 25, 2025
Bioxyne sees sharp revenue growth as shares jump after strong quarter by Steve Jones October 17, 2024February 25, 2025
Montu share buy-back offer on ice as shareholders report plan to Takeovers Panel and demand independent report by Steve Jones September 26, 2024October 25, 2024
Bioxyne forecasts doubling of revenue amid ‘$100m gummy opportunity’ by Steve Jones September 26, 2024September 26, 2024
Company news: Montu; ANTG; ECS Botanics; Tilray by Martin Lane and Steve Jones September 25, 2024January 13, 2025
